INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

78,999 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
OD
Oddie Andrew DavidCHIEF INTERNATIONAL OFFICER
FNKOFunko, Inc.
Grant or award
A—
123.8K sh
Mar 17, 2026Mar 19, 2026
Page 1314 of 1975
← PrevNext →
traded Mar 17, 2026
+2d
SEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
1.73M sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
KJ
Kreps Edward JayDirector, CHIEF EXECUTIVE OFFICER
CFLTConfluent, Inc.
Disposition to issuer
D—
1.00M sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
LY
Le Pendeven YvesCFO
FNKOFunko, Inc.
Grant or award
A—
123.8K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

5
CL
Caimi LaraDirector
CFLTConfluent, Inc.
Disposition to issuer
D—
186.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$64K
1,395 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

4
TR
Thurman Alex R.SVP & CHIEF FINANCIAL OFFICER
GKOSGLAUKOS Corp
Tax withholding · 10b5-1 plan
F$61K
614 sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

4
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
CR
Chatwani RobertPresident General Mgr, Growth
DOCUDOCUSIGN, INC.
Open-market sale · 10b5-1 plan
SELL$144K
3,085 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

4
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$2.53M
3.21M sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

4
SJ
Scaringe Robert JDirector, Chief Executive Officer
RIVNRivian Automotive, Inc. / DE
Open-market sale · 10b5-1 plan
SELL$272K
17.4K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

4
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

3
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
1.79M sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

2
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Tax withholding · 10b5-1 plan
F$157K
1,241 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Grant or award · 10b5-1 plan
A—
500.0K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
1,365 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
BS
Blake SarahSVP, Chief Accounting Officer
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
200.0K sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
37.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$2,989
1,365 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

0
PJ
Peterson JustinChief Technology Officer
TWTradeweb Markets Inc.
Grant or award · 10b5-1 plan
A—
3 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

57
FJ
Fry David JamesGroup Head Projects & Studies
NEMNEWMONT Corp /DE/
Open-market sale
SELL$2.05M
18.4K sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.33M
4,069 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.56M
4,795 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.98M
6,040 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.16M
3,574 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

50
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.35M
4,134 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.82M
5,632 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$266K
808 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$2.05M
6,405 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

47
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$568K
1,758 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

44
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Open-market purchase
BUY$223K
15.0K sh
Mar 18, 2026Mar 18, 2026
traded Mar 18, 2026
+0dSEC Form 4

Evidence

44
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$116K
360 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

43
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.86M
5,796 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence